- Home
- HKIT vs KZR Comparison
HKIT vs KZR Comparison
Compare HKIT & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- KZR
- Stock Information
- Founded
- HKIT 1996
- KZR 2015
- Country
- HKIT China
- KZR United States
- Employees
- HKIT N/A
- KZR N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- KZR Health Care
- Exchange
- HKIT Nasdaq
- KZR Nasdaq
- Market Cap
- HKIT 45.4M
- KZR 43.0M
- IPO Year
- HKIT 2023
- KZR 2018
- Fundamental
- Price
- HKIT $1.26
- KZR $6.05
- Analyst Decision
- HKIT
- KZR Hold
- Analyst Count
- HKIT 0
- KZR 2
- Target Price
- HKIT N/A
- KZR $9.00
- AVG Volume (30 Days)
- HKIT 23.4K
- KZR 26.2K
- Earning Date
- HKIT 04-08-2025
- KZR 03-13-2025
- Dividend Yield
- HKIT N/A
- KZR N/A
- EPS Growth
- HKIT N/A
- KZR N/A
- EPS
- HKIT 0.04
- KZR N/A
- Revenue
- HKIT $3,449,206.00
- KZR N/A
- Revenue This Year
- HKIT N/A
- KZR N/A
- Revenue Next Year
- HKIT N/A
- KZR N/A
- P/E Ratio
- HKIT $33.13
- KZR N/A
- Revenue Growth
- HKIT N/A
- KZR N/A
- 52 Week Low
- HKIT $1.00
- KZR $5.20
- 52 Week High
- HKIT $2.35
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- HKIT 46.17
- KZR 43.79
- Support Level
- HKIT $1.23
- KZR $5.86
- Resistance Level
- HKIT $1.34
- KZR $6.57
- Average True Range (ATR)
- HKIT 0.08
- KZR 0.27
- MACD
- HKIT 0.00
- KZR 0.02
- Stochastic Oscillator
- HKIT 57.89
- KZR 25.97
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.